BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids: Table 1

Abstract

Scope and purpose of the guideline Need for guidelinesThe prescribing of many drugs in pregnancy is complicated by a lack of knowledge regarding their compatibility leading to patient misinformation and withdrawal/denial of disease-ameliorating therapies.This situation should be avoided because active rheumatic disease is associated with adverse pregnancy outcomes [1] and there is growing evidence of drug safety in pregnancy.NICE has accredited the process used by the BSR to produce its guidance on prescribing drugs in pregnancy and breastfeeding.